Alexandre Weinstein Manieu - Oct 29, 2025 Form 4 Insider Report for Pluri Inc. (PLUR)

Role
Director, 10%+ Owner
Signature
/s/ Alexandre Weinstein Manieu
Stock symbol
PLUR
Transactions as of
Oct 29, 2025
Transactions value $
$2,087,056
Form type
4
Date filed
11/20/2025, 11:35 AM
Previous filing
Jul 1, 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Manieu Alexandre Weinstein Director, 10%+ Owner APT 8002, BURGENSTOCK HOTELS & RESORT,, BURGENSTOCK 30, OBBURGEN, SWITZERLAND /s/ Alexandre Weinstein Manieu 2025-11-20 0001833124
Chutzpah Holdings Ltd Director, 10%+ Owner 4TH FLOOR, LIBERATION HOUSE, CASTLE STREET, ST. HELIER, JERSEY /s/ Ana Ventura Authorized Officer For Beaumont (Directors) Limited Sole Corporate Director 2025-11-20 0002055515

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLUR Common Stock Award $0 +10.3K $0.00 10.3K Feb 25, 2025 Direct
transaction PLUR Common Stock Options Exercise $100 +1M +107.62% $0.00 1.93M Oct 29, 2025 Shares indirectly held through Chutzpah Holdings Limited F1, F3
transaction PLUR Common Stock Purchase $2.09M +453K $4.61 453K Apr 28, 2025 Shares indirectly held through Plantae Bioscience Ltd. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLUR Pre-Funded Warrants to purchase Common Shares Options Exercise $0 -1M -92.22% $0.00 84.6K Oct 29, 2025 Common Shares 0 $0.00 Indirectly held through Chutzpah Holdings Limited F1, F3, F4, F5, F7
transaction PLUR Common Warrants Award $0 +84.6K $0.00 84.6K Jan 23, 2025 Common Shares 0 $5.57 Indirectly held through Chutzpah Holdings Limited F1, F4, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This statement is jointly filed by and on behalf of each of Chutzpah Holdings Limited ("Chutzpah") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah.
F2 Mr. Weinstein indirectly owns 77% of Plantae Bioscience Ltd. ("Plantae") and may be deemed to beneficially own securities owned by Plantae. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by Plantae. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
F3 In connection with the issuance of common shares in a private placement transaction to Chutzpah on January 23, 2025 (previously reported by the reporting person on Form 3 filed with the Securities and Exchange Commission on February 18, 2025), the reporting person also received 26,030 prefunded warrants to purchase common shares, which, together with the 976,139 prefunded warrants to purchase common shares issued on April 25, 2025 under an amendment to its previously executed Securities Purchase Agreement, entered into on January 23, 2025 by the Company and Chutzpah, became exercisable following the Company's shareholders meeting on June 30, 2025. The total number of pre-funded warrants being reported after being exercised by the reporting person is 1,002,169 consisting of 976,139 plus 26,030 pre-funded warrants.
F4 On January 23, 2025, Pluri Inc. ("Pluri") entered into a Securities Purchase Agreement with Chutzpah, relating to a private placement offering of: (i) 1,383,948 common shares, par value $0.00001 per share of Pluri, (ii) pre-funded warrants to purchase up to 26,030 Common Shares, and (iii) common warrants to purchase up to 84,599 common shares. The reporting person had previously omitted filing a transaction that occurred on January 1, 2025, which was inadvertently omitted from a prior Form 4. The reporting person became aware of the omission on October 31,2025 and is reporting the transaction promptly after such discovery.
F5 1,002,169 pre-funded warrants are being exercised.
F6 The common warrants are exercisable until June 30, 2028.
F7 Pre-Funded Warrants were acquired in exchange for common shares. Common Warrants were issued as part of the January 23, 2025 transaction for no additional consideration.

Remarks:

Exhibit Index: Exhibit 99.1 - Joint Filer Information (incorporated by reference to Exhibit 99.1 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Exhibit 99.2 - Joint Filing Agreement (incorporated by reference to Exhibit 99.2 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.